These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1114 related items for PubMed ID: 7658980

  • 1. [Review of oral cephalosporins. Basis for a rational choice].
    Forti IN.
    Medicina (B Aires); 1994; 54(5 Pt 1):439-58. PubMed ID: 7658980
    [Abstract] [Full Text] [Related]

  • 2. Third-generation cephalosporins: a critical evaluation.
    Barriere SL, Flaherty JF.
    Clin Pharm; 1984; 3(4):351-73. PubMed ID: 6432420
    [Abstract] [Full Text] [Related]

  • 3. Cefepime: the next generation?
    Sanders CC.
    Clin Infect Dis; 1993 Sep; 17(3):369-79. PubMed ID: 8218678
    [Abstract] [Full Text] [Related]

  • 4. Antibiotic use in neonatal sepsis.
    Yurdakök M.
    Turk J Pediatr; 1998 Sep; 40(1):17-33. PubMed ID: 9722468
    [Abstract] [Full Text] [Related]

  • 5. Ceftaroline: a new cephalosporin with activity against resistant gram-positive pathogens.
    Steed ME, Rybak MJ.
    Pharmacotherapy; 2010 Apr; 30(4):375-89. PubMed ID: 20334458
    [Abstract] [Full Text] [Related]

  • 6. Tigecycline: first of a new class of antimicrobial agents.
    Rose WE, Rybak MJ.
    Pharmacotherapy; 2006 Aug; 26(8):1099-110. PubMed ID: 16863487
    [Abstract] [Full Text] [Related]

  • 7. The selection and use of cephalosporins: a review.
    Klein NC, Cunha BA.
    Adv Ther; 1995 Aug; 12(2):83-101. PubMed ID: 10150326
    [Abstract] [Full Text] [Related]

  • 8. Update of cefditoren activity tested against community-acquired pathogens associated with infections of the respiratory tract and skin and skin structures, including recent pharmacodynamic considerations.
    Biedenbach DJ, Jones RN.
    Diagn Microbiol Infect Dis; 2009 Jun; 64(2):202-12. PubMed ID: 19321284
    [Abstract] [Full Text] [Related]

  • 9. Newer cephalosporins and cephamycins--a review.
    Norrby R.
    Scand J Infect Dis Suppl; 1978 Jun; (13):83-7. PubMed ID: 356183
    [Abstract] [Full Text] [Related]

  • 10. Cefepime: a new fourth-generation cephalosporin.
    Okamoto MP, Nakahiro RK, Chin A, Bedikian A, Gill MA.
    Am J Hosp Pharm; 1994 Feb 15; 51(4):463-77; quiz 541-2. PubMed ID: 8017411
    [Abstract] [Full Text] [Related]

  • 11. Basic design of beta-lactam antibiotics--cephalosporins.
    Price KE, McGregor DN.
    Scand J Infect Dis Suppl; 1984 Feb 15; 42():50-63. PubMed ID: 6597562
    [Abstract] [Full Text] [Related]

  • 12. [Current antibiotics for clinical practice].
    Zimmerli W.
    Praxis (Bern 1994); 1996 Oct 01; 85(40):1240-4. PubMed ID: 8966413
    [Abstract] [Full Text] [Related]

  • 13. In vitro activity, pharmacokinetics, clinical efficacy, safety and pharmacoeconomics of ceftriaxone compared with third and fourth generation cephalosporins: review.
    Bijie H, Kulpradist S, Manalaysay M, Soebandrio A.
    J Chemother; 2005 Feb 01; 17(1):3-24. PubMed ID: 15828439
    [Abstract] [Full Text] [Related]

  • 14. Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
    Jones RN, Sader HS, Fritsche TR, Pottumarthy S.
    Diagn Microbiol Infect Dis; 2007 Jan 01; 57(1):109-16. PubMed ID: 16930923
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [The history of the development and changes of quinolone antibacterial agents].
    Takahashi H, Hayakawa I, Akimoto T.
    Yakushigaku Zasshi; 2003 Jan 01; 38(2):161-79. PubMed ID: 15143768
    [Abstract] [Full Text] [Related]

  • 17. Third-generation cephalosporins: a review.
    Cunha BA.
    Clin Ther; 1992 Jan 01; 14(5):616-52; discussion 615. PubMed ID: 1468084
    [Abstract] [Full Text] [Related]

  • 18. Multicentre study of the in vitro activity of cefepime, a broad-spectrum cephalosporin, compared to other broad-spectrum agents.
    Bell JM, Turnidge JD, Cefepime Study Group.
    Pathology; 2001 Feb 01; 33(1):53-60. PubMed ID: 11280610
    [Abstract] [Full Text] [Related]

  • 19. An in vitro characterization of cefditoren, a new oral cephalosporin.
    Felmingham D, Robbins MJ, Ghosh G, Bhogal H, Mehta MD, Leakey A, Clark S, Dencer CA, Ridgway GL, Grüneberg RN.
    Drugs Exp Clin Res; 1994 Feb 01; 20(4):127-47. PubMed ID: 7813385
    [Abstract] [Full Text] [Related]

  • 20. The role of newer antibiotics in gastroenterology.
    Li E, Stanley SL.
    Gastroenterol Clin North Am; 1992 Sep 01; 21(3):613-29. PubMed ID: 1516960
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 56.